Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
Syngene International Ltd in Bangalore is seeking a Study Director - Pharmacokinetics and Immunogenicity Assays to lead bioanalytical activities, specializing in ligand binding assays for PK and Immunogenicity.
The role requires 6–9 years in an immunoassay lab, with hands-on LBA development, validation, and sample analysis; familiarity with ELISA and MSD, regulatory guidelines (OECD, GXP, 21 CFR Part 11, EMA, FDA), and proficiency in LIMS, GraphPad and Adobe.
Date: 4 Nov 2026
Location:
Bangalore, KA, IN, 560100
Division: Discovery Services
Job Title: Study Director - Pharmacokinetics and Immunogenicity Assays
Job Location: Bangalore
Department: Translational and Clinical Research About Syngene
Incorporated in 1993, Syngene International Ltd. is an innovation-focused global discovery, development and manufacturing organization providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’ s clientele includes world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4240-strong team of scientists who work with clients from around the world to solve their scientific problems, improve R& productivity, speed up time to market and lower the cost of innovation.
Job Purpose: The position holder is responsible for performing bioanalysis which includes performing ligand binding assays related to Pharmacokinetics and Immunogenicity.
Key Responsibilities
Experience
It is the policy of Syngene to provide equal employment opportunity (EEO) to all persons regardless of age, color, national origin, citizenship status, physical or mental disability, race, religion, creed, gender, sex, sexual orientation, gender identity and/or expression, genetic information, marital status, status with regard to public assistance, veteran status, or any other characteristic protected by applicable legislation or local law. In addition, Syngene will provide reasonable accommodation for qualified individuals with disabilities.